Back to search
Biliary Atresia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Atresia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Atresia trials you may qualify forBiliary atresia is a rare, progressive liver disease that only affects infants. It leads to complete obstruction and scarring of the bile duct. Current non-inva…
This study is a prospective, single center and observational open clinical study.
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
In infants that present with findings concerning for biliary atresia, along with other cholestatic work up which is standard, they will receive a one-time intra…
Infants with biliary atresia (Biliary atresia, BA) have an increased risk of malnutrition due to insufficient dietary intake to maintain normal growth, impaired…
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the per…
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia
Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary at…
This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investi…